(Q40129380)

17 September 2017

1 reference

title

Preparation and properties of human C1 inhibitor (English)

1 reference

17 September 2017

5 Preparation and properties of human inhibitor (English)

1 reference

https://api.crossref.org/works/10.1016/S0076-6879(81)80007-9

15 September 2023

author name string

R. B. Sim

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6281621

15 September 2023

A. Reboul

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6281621

15 September 2023

language of work or name

English

0 references

publication date

1 January 1981

1 reference

17 September 2017

published in

Methods in Enzymology

1 reference

17 September 2017

volume

80 Pt C

1 reference

17 September 2017

page(s)

43-54

1 reference

Some properties of an esterase derived from preparations of the first component of complement

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

Interaction of 125I-labelled complement subcomponents C-1r and C-1s with protease inhibitors in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

A simplified procedure for the purification of C1-inactivator from human plasma. Interaction with complement subcomponents C1r and C1s

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

Kinetics of reaction of human C-inhibitor with the human complement system proteases Cr and Cs

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

Complement: purification of the first component from rabbit and guinea pig serum

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

Purification of proenzymic and activated human C1s free ofC1r. Effect of calcium and ionic strength on activated C1s

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

Development of an immunochemical test to assess C1 inactivator function in human serum and its use for the diagnosis of hereditary angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

Studies on human plasma C1 inactivator-enzyme interactions. I. Mechanisms of interaction with C1s, plasmin, and trypsin

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

Purification and some properties of rabbit C1 inactivator

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

Phylogeny and Function of the Complement System

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

Isolation and characterization of C1-Inactivator from human plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C'1r subcomponent of the first component of complement by serum C'1 esterase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

Inhibition by C1INH of Hagemann factor fragment activation of coagulation, fibrinolysis, and kinin generation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

Plasmin inhibitor interactions. The effectiveness of alpha2-plasmin inhibitor in the presence of alpha2-macroglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

Anticoagulant Action of Heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

Interaction of C1-inhibitor with the C1r and C1s subcomponents in human C1

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

C1 inhibitor-dependent dissociation of human complement component C1 bound to immune complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

Formation and dissociation of the covalent complexes between trypsin and two homologous inhibitors, alpha 1-antitrypsin and antithrombin III

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

Effect of C1-inhibitor, benzamidine, and heat treatment on the hydrolytic activity of a subcomponent of the first component of human complement, C1s

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

Inactivator of the first component of human complement (C1INA). Enhancement of C1INA activity against C1s by acidic mucopolysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2881%2980007-9

7 January 2021

Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie

6

18

17

Schena

1980

1 reference

https://api.crossref.org/works/10.1016/S0076-6879(81)80007-9

Complement: A Host Defense Mechanism Ready for Pharmacological Manipulation?

15 September 2023

series ordinal

40

1 reference

https://api.crossref.org/works/10.1016/S0076-6879(81)80007-9

15 September 2023

Identifiers

1 reference

17 September 2017

1 reference